|
GOLGA4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.72779626348574E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.41809997078468E-09 |
| Normal-vs-Stage2 |
8.993100E-04 |
| Normal-vs-Stage3 |
8.90880036408248E-10 |
| Normal-vs-Stage4 |
1.15910000486608E-08 |
| Stage1-vs-Stage2 |
1.520990E-01 |
| Stage1-vs-Stage3 |
2.407200E-01 |
| Stage1-vs-Stage4 |
1.953550E-01 |
| Stage2-vs-Stage3 |
4.064400E-02 |
| Stage2-vs-Stage4 |
3.549800E-02 |
| Stage3-vs-Stage4 |
7.141600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.26154683658342E-12 |
| Normal-vs-AfricanAmerican |
5.062700E-03 |
| Normal-vs-Asian |
2.89110002604787E-09 |
| Caucasian-vs-AfricanAmerican |
1.166380E-01 |
| Caucasian-vs-Asian |
4.048600E-01 |
| AfricanAmerican-vs-Asian |
5.031900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0258018313134E-11 |
| Normal-vs-Female |
2.65849997571621E-09 |
| Male-vs-Female |
1.052160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.49590001391675E-09 |
| Normal-vs-Age(41-60Yrs) |
3.84109966056201E-10 |
| Normal-vs-Age(61-80Yrs) |
6.54090000051788E-07 |
| Normal-vs-Age(81-100Yrs) |
4.000400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.207600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.683000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.346600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.035400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.975800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.475200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.187810E-01 |
| Classical-VS-Follicular |
3.757700E-03 |
| Classical-VS-Other |
2.813200E-01 |
| Classical-VS-Normal |
4.24316137781489E-12 |
| Tall-VS-Follicular |
3.151700E-04 |
| Tall-VS-Other |
7.436800E-01 |
| Tall-VS-Normal |
8.36809954662954E-10 |
| Follicular-VS-Other |
1.081910E-02 |
| Follicular-VS-Normal |
4.357700E-03 |
| Other-VS-Normal |
4.373000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2391999981709E-08 |
| Normal-vs-N1 |
1.50120027520018E-10 |
| N0-vs-N1 |
2.421800E-02 |
|
|
